Literature DB >> 21050394

International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation.

Stanley E Althof1, Carmita H N Abdo, John Dean, Geoff Hackett, Marita McCabe, Chris G McMahon, Raymond C Rosen, Richard Sadovsky, Marcel Waldinger, Edgardo Becher, Gregory A Broderick, Jacques Buvat, Irwin Goldstein, Amr I El-Meliegy, Francois Giuliano, Wayne J G Hellstrom, Luca Incrocci, Emmanuele A Jannini, Kwangsung Park, Sharon Parish, Hartmut Porst, David Rowland, Robert Segraves, Ira Sharlip, Chiara Simonelli, Hui Meng Tan.   

Abstract

INTRODUCTION: Over the past 20 years our knowledge of premature ejaculation (PE) has significantly advanced. Specifically, we have witnessed substantial progress in understanding the physiology of ejaculation, clarifying the real prevalence of PE in population-based studies, reconceptualizing the definition and diagnostic criterion of the disorder, assessing the psychosocial impact on patients and partners, designing validated diagnostic and outcome measures, proposing new pharmacologic strategies and examining the efficacy, safety and satisfaction of these new and established therapies. Given the abundance of high level research it seemed like an opportune time for the International Society for Sexual Medicine (ISSM) to promulgate an evidenced-based, comprehensive and practical set of clinical guidelines for the diagnosis and treatment of PE. AIM: Develop clearly worded, practical, evidenced-based recommendations for the diagnosis and treatment of PE for family practice clinicians as well as sexual medicine experts. Method.  Review of the literature.
RESULTS: This article contains the report of the ISSM PE Guidelines Committee. It affirms the ISSM definition of PE and suggests that the prevalence is considerably lower than previously thought. Evidence-based data regarding biological and psychological etiology of PE are presented, as is population-based statistics on normal ejaculatory latency. Brief assessment procedures are delineated and validated diagnostic and treatment questionnaires are reviewed. Finally, the best practices treatment recommendations are presented to guide clinicians, both familiar and unfamiliar with PE, in facilitating treatment of their patients.
CONCLUSION: Development of guidelines is an evolutionary process that continually reviews data and incorporates the best new research. We expect that ongoing research will lead to a more complete understanding of the pathophysiology as well as new efficacious and safe treatments for this sexual dysfunction. Therefore, it is strongly recommended that these guidelines be re-evaluated and updated by the ISSM every 4 years.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21050394     DOI: 10.1111/j.1743-6109.2010.01975.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  74 in total

1.  Discovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood-Brain Barrier Penetration.

Authors:  Xin Li; Zhigao Zhang; Yang Chen; Hong Wan; Jiakang Sun; Bin Wang; Bingqiang Feng; Bing Hu; Xingxing Shi; Jun Feng; Lei Zhang; Feng He; Chang Bai; Lianshan Zhang; Weikang Tao
Journal:  ACS Med Chem Lett       Date:  2019-05-29       Impact factor: 4.345

2.  Erectile dysfunction and premature ejaculation in men who have sex with men.

Authors:  Alan W Shindel; Eric Vittinghoff; Benjamin N Breyer
Journal:  J Sex Med       Date:  2012-01-03       Impact factor: 3.802

Review 3.  Efficacy of PDE5Is and SSRIs in men with premature ejaculation: a new systematic review and five meta-analyses.

Authors:  Yi Sun; Lu Yang; Yige Bao; Zhenhua Liu; Liangren Liu; Qiang Wei
Journal:  World J Urol       Date:  2017-09-14       Impact factor: 4.226

4.  Abnormal degree centrality in lifelong premature ejaculation patients: an fMRI study.

Authors:  Ming Gao; Nana Feng; Xiang Liu; Jianhua Sun; Guangdong Hou; Lei Zhang; Hong Yin; Boda Guo; Jiayu Wu; Mengmeng Huang; Jianlin Yuan; Jun Guo; Peng Liu
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

5.  Paternal dapoxetine administration induced deterioration in reproductive performance, fetal outcome, sexual behavior and biochemistry of male rats.

Authors:  R ElMazoudy; N AbdelHameed; A ElMasry
Journal:  Int J Impot Res       Date:  2015-09-24       Impact factor: 2.896

6.  Dapoxetine: a new option in the medical management of premature ejaculation.

Authors:  Chris G McMahon
Journal:  Ther Adv Urol       Date:  2012-10

7.  Smaller volume and altered functional connectivity of the amygdala in patients with lifelong premature ejaculation.

Authors:  Bowen Geng; Ming Gao; Jiayu Wu; Guang Yang; Chengxiang Liu; Ruiqing Piao; Shuming Zhang; Ke Xu; Jianlin Yuan; Peng Liu
Journal:  Eur Radiol       Date:  2021-04-30       Impact factor: 5.315

Review 8.  New insights on premature ejaculation: a review of definition, classification, prevalence and treatment.

Authors:  Ege C Serefoglu; Theodore R Saitz
Journal:  Asian J Androl       Date:  2012-10-15       Impact factor: 3.285

9.  A reassessment of penile sensory pathways and effects of prilocaine-lidocaine cream in primary premature ejaculation.

Authors:  J-D Xia; L-H Zhou; Y-F Han; Y Chen; R Wang; Y-T Dai
Journal:  Int J Impot Res       Date:  2014-02-27       Impact factor: 2.896

Review 10.  Efficacy and safety of local anaesthetics for premature ejaculation: a systematic review and meta-analysis.

Authors:  Jia-Dong Xia; You-Feng Han; Liu-Hua Zhou; Yun Chen; Yu-Tian Dai
Journal:  Asian J Androl       Date:  2013-05-27       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.